Alector (ALEC) Return on Capital Employed (2019 - 2026)
Alector's (ALEC) quarterly Return on Capital Employed came in at 60.38% in Q1 2026, down 1595.0% year-on-year from 4.04% in Q1 2025, and up 5.27% on a QoQ basis from 63.74% in Q4 2025.
Alector (ALEC) Return on Capital Employed (2019 - 2026) Analysis & Trends
Alector (ALEC) has 8 years of Return on Capital Employed data on file, last reported at 60.38% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 1595.0% year-over-year to 60.38% in Q1 2026; TTM through Mar 2026 was 60.38%, a 1595.0% decrease from a year earlier, with the FY2025 full-year figure at 50.12%, down 1560.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 60.38%, up from 63.74% in the prior quarter.
- Over the last five years, Return on Capital Employed for ALEC reached as high as 4.65% in Q2 2022 and fell as low as 63.74% in Q4 2025.
- Historically, Return on Capital Employed has averaged 33.32% across 5 years, with a median of 32.34% in 2023.
- Across the five-year window, Return on Capital Employed jumped 6694 bps in 2022 and slumped 3096 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 19.18% in 2022, then tumbled by 69 bps to 32.34% in 2023, then retreated by 22 bps to 39.5% in 2024, then tumbled by 61 bps to 63.74% in 2025, then gained by 5 bps to 60.38% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 60.38% in Q1 2026, 63.74% in Q4 2025, and 46.52% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | -60.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.38% |
| Dec 31, 2025 | -63.74% |
| Sep 30, 2025 | -46.52% |
| Jun 30, 2025 | -45.14% |
| Mar 31, 2025 | -44.44% |
| Dec 31, 2024 | -39.50% |
| Sep 30, 2024 | -46.20% |
| Jun 30, 2024 | -41.14% |
| Mar 31, 2024 | -31.34% |
| Dec 31, 2023 | -32.34% |
| Sep 30, 2023 | -29.85% |
| Jun 30, 2023 | -26.31% |
| Mar 31, 2023 | -21.51% |
| Dec 31, 2022 | -19.18% |
| Sep 30, 2022 | -19.66% |
| Jun 30, 2022 | 4.65% |
| Mar 31, 2022 | -3.89% |
| Dec 31, 2021 | -5.38% |
| Sep 30, 2021 | -6.98% |
| Jun 30, 2021 | -62.28% |